Argenx SE Partners with Monica Seles to Raise Awareness for Myasthenia Gravis
Argenx SE, a biotechnology company focused on antibody-based therapies for severe autoimmune diseases and cancer, has announced a partnership with tennis legend Monica Seles. The collaboration aims to raise awareness for myasthenia gravis, a chronic autoimmune disease affecting thousands of people worldwide.
The partnership is part of Argenx’s ‘Go for Greater’ patient support initiative, which connects patients with resources and fosters community engagement. This initiative is designed to provide support to patients and their families affected by rare diseases.
Key aspects of the partnership include:
- Promotion of the ‘Go for Greater’ patient support initiative
- Raising awareness for myasthenia gravis and other rare diseases
- Community engagement and resource connection for patients
The collaboration will be showcased at the 2025 U.S. Open Tennis Championships, where Argenx serves as a premier global sponsor. This move highlights the company’s commitment to supporting patients and raising awareness for rare diseases.